The Australian Therapeutic Goods Administration (TGA) has issued a warning about GLP-1 drugs like Ozempic, linking them to a rare but severe eye disorder known as NAION. This condition can lead to permanent vision loss, prompting urgent medical advice.
What Is NAION?
Non-arteritic anterior ischaemic optic neuropathy (NAION) is a rare eye disorder that affects the optic nerve, potentially causing sudden vision loss. The TGA reported 36 cases linked to GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro. Currently, no treatment has been shown to improve visual outcomes after NAION develops.
Get the #1 Wireless Door Camera
REOLINK Bestseller: 2K Weatherproof Video Doorbell, No Monthly Fees.
Key Risks and Statistics
The TGA updated product information for these medications to include the warning. Patients experiencing sudden vision changes—even partial loss—should seek urgent medical attention. However, experts stress that NAION remains extremely rare compared to the common conditions these drugs treat, such as heart attacks, stroke, and kidney disease.
| Medication | Active Ingredient | Reported NAION Cases (Australia) |
|---|---|---|
| Ozempic | Semaglutide | 36 (all GLP-1 RAs combined) |
| Wegovy | Semaglutide | Included in total |
| Mounjaro | Tirzepatide | Included in total |
Expert Perspective
Prof Helen Danesh-Meyer from the Royal Australian and New Zealand College of Ophthalmologists advises putting the risk in perspective. “Blindness is a great concern, but NAION is very rare while the conditions these drugs prevent are common and life-threatening.” She recommends continuing medication under doctor supervision unless advised otherwise.
Key Takeaways
- The TGA has linked GLP-1 drugs to a rare but severe eye disorder called NAION.
- Reported cases in Australia: 36 across Ozempic, Wegovy, and Mounjaro.
- Patients should seek urgent medical help if they experience sudden vision loss.
- Do not stop medication without consulting your doctor.
- Experts emphasize the benefits of these drugs for managing diabetes and obesity outweigh the rare risk.
FAQ
What is NAION and how is it linked to Ozempic?
NAION is a rare optic nerve disorder that can cause permanent vision loss. The TGA found a potential link between GLP-1 drugs like Ozempic and an increased risk of NAION based on a 2024 study and ongoing monitoring.
Should I stop taking Ozempic if I'm worried about eye problems?
No. The TGA advises not to stop treatment without consulting a doctor. The benefits of these medications for diabetes and obesity generally outweigh the rare risk of NAION. Speak to your healthcare provider about any concerns.
How common is NAION among GLP-1 users in Australia?
As of the latest TGA warning, 36 cases have been reported in Australia. Given the millions of prescriptions, NAION remains very rare. However, patients should remain vigilant for sudden vision changes.
Home Decor Shop
Acacia frida deluxe solid wood bed frame |
Bedroom bench |
Bed chest drawers |
Lingerie dresser |
Frame base |
Mirror with jewelry storage |
30 Bathroom Vanity |
Memory foam queen mattress |
Mattresses for back pain |
Nightstand set of 2 |
Grand Goldman Shop |
Civil Lawyer
Deutschland Trikot WM 2026
